Company registration number 08282625 (England and Wales)
MEDSERENA UPRIGHT MRI LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
MEDSERENA UPRIGHT MRI LTD
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 5
MEDSERENA UPRIGHT MRI LTD
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Current assets
Debtors
3
407,512
1,908,195
Cash at bank and in hand
26,423
776
433,935
1,908,971
Creditors: amounts falling due within one year
4
(172,466)
(194,302)
Net current assets
261,469
1,714,669
Creditors: amounts falling due after more than one year
5
(20,834)
Net assets
261,469
1,693,835
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
261,468
1,693,834
Total equity
261,469
1,693,835
For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 28 May 2026 and are signed on its behalf by:
J Hyka
Director
Company registration number 08282625 (England and Wales)
MEDSERENA UPRIGHT MRI LTD
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 January 2024
1
1,541,525
1,541,526
Year ended 31 December 2024:
Profit and total comprehensive income
-
152,309
152,309
Balance at 31 December 2024
1
1,693,834
1,693,835
Year ended 31 December 2025:
Profit and total comprehensive income
-
319,427
319,427
Dividends
-
(1,751,793)
(1,751,793)
Balance at 31 December 2025
1
261,468
261,469
MEDSERENA UPRIGHT MRI LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information
Medserena Upright MRI Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 114a Cromwell Road, Kensington, London, SW7 4ES.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention.
1.2
Turnover
Turnover represents amounts receivable for the provision of MRI scans and other related services from an upright scanner and is recognised as soon as those services are provided and invoiced, net of VAT.
1.3
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.
1.4
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include trade and other debtors, cash and bank balances and amounts due from fellow group companies, are measured at transaction price including transaction costs. Financial assets classified as receivable within one year are not amortised.
Basic financial liabilities
Basic financial liabilities, including trade and other creditors, bank loans and tax liabilities, are recognised at transaction price. Financial liabilities classified as payable within one year are not amortised.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised at transaction price.
MEDSERENA UPRIGHT MRI LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.6
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.7
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
17
17
3
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
400,892
333,657
Amounts owed by group undertakings
1,560,722
Other debtors
6,620
13,816
407,512
1,908,195
4
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loan
20,834
50,000
Trade creditors
104,809
111,508
Taxation and social security
17,149
15,776
Other creditors
29,674
17,018
172,466
194,302
MEDSERENA UPRIGHT MRI LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
5
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loan
20,834
6
Parent company
The ultimate parent company of Medserena Upright MRI Ltd is Medserena Ag and its registered office is 44 Maternusstr., 50996, Koln, Germany.